Akèy › Dyabèt Tip 2 › Lwizyàn
Etid klinik pou Dyabèt Tip 2 nan Lwizyàn
15 etid pou Dyabèt Tip 2 ap chèche patisipan nan sit nan Lwizyàn.
Vil nan Lwizyàn
Tèks ofisyèl etid la (Anglè)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Grace Research, LLC-Bossier City-51040, Bossier City
- Louisiana Heart Center - Covington, Covington
- IMA Clinical Research Monroe, Monroe
- ak 4 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Ascension DePaul Services Research Center, New Orleans
Ap rekriteVolontè an sante akeyi
Laj 55 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06112418A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Clinical Trials Management, LLC d/b/a Flourish Research, Metairie
- IMA Clinical Research Monroe - Armand, Monroe
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Monroe
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Baton Rouge
- AURORA-2 Clinical Site, Metairie
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Elevate Clinical Research, Lake Charles
- Nola Care Clinical Research Center, Metairie
- DelRicht Clinical Research, LLC, New Orleans
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07351058Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- IMA Clinical Research, Monroe
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2026 · NCT07271186Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Velocity Clinical Research, Lafayette, Lafayette
- NOLA Care Clinical Research, Metairie
- Tulane University School of Medicine, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07296484Enhancing Diabetes Care by Treating Insomnia
- Southeast Community Health Systems, Zachary
Ap rekrite
Laj 40 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT07062406AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Louisiana Heart Center, Covington
Ap rekriteFaz 3
Laj 45 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Zachary
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Covington
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT07662044Continuous Glucose Monitoring (CGM) in an Underserved Population
- University Medical Center, New Orleans
Ap rekrite
Laj 18 a 75 · Tout sèks · Mizajou May 5, 2026 · NCT07135531HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Tandem Clinical Research (Interspond), Marrero
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Apr 23, 2026 · NCT07546929Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
- Poirot Podiatry, Metairie
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 27, 2024 · NCT06674980Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.